FURET PASCAL has a total of 26 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are 3 V BIOSCIENCES INC, G D SEARLE & CO CHICAGO and SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 22 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Furet Pascal | 26 |
#2 | Schoepfer Joseph | 9 |
#3 | Guagnano Vito | 7 |
#4 | Grotzfeld Robert Martin | 6 |
#5 | Salem Bahaa | 6 |
#6 | Jahnke Wolfgang | 6 |
#7 | Pelle Xavier Francois Andre | 6 |
#8 | Stauffer Frederic | 6 |
#9 | Marzinzik Andreas | 6 |
#10 | Manley Paul William | 6 |
Publication | Filing date | Title |
---|---|---|
US2015353551A1 | Substituted purinone compounds | |
US2015126485A1 | Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | |
US2014350010A1 | Pyrazolopyrrolidine compounds | |
US2014249139A1 | Quinazoline Derivatives | |
US2011039831A1 | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives | |
US2010311714A1 | 1H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDS |